Back
Moderna, Inc. 10K Form
Sell
42
MRNA
Moderna, Inc.
Last Price:
$25.50
Seasonality Move:
-9.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MRNA News And Ratings
See the #1 stock for the next 7 days that we like better than MRNA
MRNA Financial Statistics
Sales & Book Value
| Annual Sales: | $3.2B |
|---|---|
| Cash Flow: | $-880M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $23.86 |
| Price / Book: | 1.05 |
Profitability
| EPS (TTM): | -8.06370 |
|---|---|
| Net Income (TTM): | $-3.1B |
| Gross Margin: | $1.6B |
| Return on Equity: | -30.18% |
| Return on Assets: | -23.33% |
Moderna, Inc. Earnings Forecast
Key Moderna, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for MRNA is 48.92%.
-
The Selling, General & Administrative Expenses for MRNA have been equal to 36.28% of Gross Profit Margin.
-
The Research & Development expenses have been 134.55% of Revenue.
-
The Net Earning history of MRNA is -110.04% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Moderna, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MRNA |
| CUSIP: | 60770K |
| Website: | modernatx.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 3.93 |
| Quick Ratio: | 3.3 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MRNA Technical Analysis vs Fundamental Analysis
Sell
42
Moderna, Inc. (MRNA)
is a Sell
Is Moderna, Inc. a Buy or a Sell?
-
Moderna, Inc. stock is rated a SellThe current Moderna, Inc. [MRNA] share price is $25.18. The Score for MRNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.